Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LataMed AILMED -5.52%23 EV-to-EBIT is -485.98 as of Sep. 02, 2026. GuruFocus rates LMED with a GF Score™ of 23/100. The stock has 2 warning signs investors should review. Among 1,766 Software companies, LataMed AI ranks worse than 56625.08% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
LataMed AI's Enterprise Value for the quarter that ended in Jun. 2026 was $132.73 Mil.
LataMed AI's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.26 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LataMed AI EV-to-EBIT Related Terms
LataMed AI EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for LataMed AI's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Application subindustry, LataMed AI's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LataMed AI EV-to-EBIT vs Software Industry
For the Software industry and Technology sector, LataMed AI's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where LataMed AI's EV-to-EBIT falls into.
LataMed AI's current Enterprise Value is $124.41 Mil.
LataMed AI's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.26 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LataMed AI (LMED) has a EV-to-EBIT of -485.98 as of Sep. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on LataMed AI and its competitors. According to the industry distribution chart, LataMed AI ranks #999999 out of 1766 companies in the Software industry.
Is LataMed AI's EV-to-EBIT too high?
LataMed AI's current EV-to-EBIT is -485.98. Based on the distribution chart, LataMed AI ranks #999999 out of 1766 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, LataMed AI has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does LataMed AI's EV-to-EBIT compare to RYDE and RDZN?
According to the Software industry distribution chart, LataMed AI ranks #999999 out of 1766 companies for EV-to-EBIT. This places LataMed AI in the lower half of its industry. The industry median EV-to-EBIT is 13.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Software company?
The median EV-to-EBIT among Software companies is 13.85, based on 1,766 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on LataMed AI and its competitors. For the Software industry, the median EV-to-EBIT is 13.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LataMed AI's current EV-to-EBIT is -485.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LataMed AI stock overvalued right now?
LataMed AI (LMED) has a current EV-to-EBIT of -485.98. The current EV-to-EBIT is -485.98. LataMed AI's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For LataMed AI (LMED), the current EV-to-EBIT is -485.98 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
LataMed AI Corp is a technology company focused on the development and deployment of artificial intelligence-driven healthcare solutions across Latin America. Its healthcare platform includes AI-enabled analytics, telehealth infrastructure, and coordinated care systems designed to support healthcare delivery in emerging markets. The company develops digital infrastructure for patient prioritization, clinical workflow management, telehealth access, care coordination, and healthcare system operations. It holds issued patents for its core AI modules-CardioAI, PulmoAI, and NeuroAI-which deliver predictive analytics for cardiovascular, pulmonary, and neurological disease detection and management.
23GF Score
Get the complete analysis for LMED
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMED has been successfully added to your 
